The Changing Approach to DR: Comanaging with the Retina Spec -

Overview
This live virtual meeting, hosted by Ehsan Rahimi, MD, will focus on the importance of collaborative care, the additional care that must be addressed when undergoing ocular surgery, the benefits of diabetic eye exams, and early treatment of retinal disease. This independent educational activity is supported by an unrestricted educational grant from Genentech, a member of the Roche Group.
Learning Objectives
Upon completion of this activity, the participant should be able to:
- Describe the increasing prevalence of diabetes and diabetic retinopathy.
- Identify and implement screening guidelines for patients based on their risk factors.
- Explain to patients the need for early referral to a retina specialist.
- Understand advances in imaging and how these allow for earlier diagnosis of disease or disease progression.
- Identify the novel therapies under investigation.
Accreditation
Evolve is an approved COPE Administrator. This course is COPE approved for 2.0 hours of CE Credit for Optometrists. Course ID: 69754-PS Activity #: 120318
Participation Method
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

Course Viewing Requirements
Supported Browsers: Internet Explorer 11 for Windows Edge (recent versions; Chromium-based) for Windows Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux Safari (recent versions) for Mac OSX, or iOS
Hardware Requirements: 4GB+ RAM
Recommended internet speed 5Mbps+
Faculty and Disclosures
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
Faculty:
Ehsan Rahimy, MD Vitreoretinal Disease & Surgery Palo Alto Medical Foundation DISCLOSURE POLICY It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity. The following faculty/staff members have the following financial relationships with commercial interests: Ehsan Rahimy, MD and or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Apellis, Carl Zeiss Meditec, Google, and Regeneron. Speakers Bureau: Allergan and Regeneron. The Evolve staff and planners have no financial relationships with commercial interests. Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.
Disclaimer
OFF-LABEL STATEMENT This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. DISCLAIMER The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Genentech, a member of the Roche group.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
  Apple Safari for Mac OS and iOS
  Mozilla Firefox for Windows, Mac OS, iOS, and Android
  Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Expiration Date: 12/02/2020

Title

Share on ReachMD